DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Fenretinide is an investigational drug.
There have been 48 clinical trials for Fenretinide. The most recent clinical trial was a Phase 3 trial, which was initiated on June 1st 2000.
The most common disease conditions in clinical trials are Neuroblastoma, Lymphoma, and Head and Neck Neoplasms. The leading clinical trial sponsors are National Cancer Institute (NCI), M.D. Anderson Cancer Center, and South Plains Oncology Consortium.
Recent Clinical Trials for Fenretinide
|Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma||Rush University Medical Center||Phase 1|
|Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma||SciTech Development, LLC||Phase 1|
|Study of LAU-7b for the Treatment of COVID-19 Disease in Adults||Laurent Pharmaceuticals Inc.||Phase 2|